Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Quest Diagnostics EPS Tops Predictions


Quest Diagnostics (NYSE:DGX), a leader in diagnostic testing and information services, released its fourth quarter results on Jan. 30. The company reported a notable quarter with adjusted earnings per share (EPS) of $2.23, surpassing the analyst projection of $2.18. Additionally, revenue reached $2.62 billion, exceeding the expected $2.58 billion.

Overall, Quest had a successful quarter, driven by strategic acquisitions and advancements in its diagnostics portfolio.

Source: Analyst estimates for the quarter provided by FactSet.

Continue reading


Source Fool.com

Like: 0
DGX
Share

Comments